| Group-A HD-responsive type | Group-B chronic type | Group-C fatigue-free type | P |
---|---|---|---|---|
N | 38 (40.0%) | 11 (11.6%) | 46 (48.4%) | Â |
Age (years) | 71.2 ± 8.8 | 66.9 ± 11.4 | 72.7 ± 9.8 | NS |
Male (%) | 19 (50.0%) | 5 (45.5%) | 30 (65.2%) | NS |
HD vintage (years) | 11.4 ± 10.1 | 19.4 ± 12.6 | 7.8 ± 7.8 | 0.001 |
A versus C: 0.001 | ||||
B versus C: 0.045 | ||||
Modality (HD/OLHDF) | 22/16 | 9/2 | 31/15 | NS |
Presence of DM | 9 (23.7%) | 2 (18.2%) | 18 (39.1%) | NS |
Body weight (kg) | 54.8 ± 13.8 | 50.4 ± 11.5 | 55.3 ± 10.8 | NS |
SBP and DBP (mmHg) before HD | 137 ± 20 | 142 ± 38 | 141 ± 25 | NS |
73 ± 13 | 75 ± 19 | 76 ± 16 | NS | |
UF volume/session (kg) | 2.6 ± 0.8 | 2.0 ± 0.8 | 2.3 ± 0.8 | NS |
History CVD | 5 (13.2%) | 4 (36.4%) | 10 (21.7%) | Â |
Creatinine (mg/dL) | 9.5 ± 2.0 | 8.6 ± 1.5 | 9.6 ± 2.2 | NS |
Hemoglobin (g/dL) | 11.1 ± 1.2 | 11.4 ± 0.7 | 11.3 ± 1.2 | NS |
Albumin (g/dL) | 3.41 ± 0.26 | 3.25 ± 0.34 | 3.42 ± 0.32 | NS |